Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T01:47:54.274Z Has data issue: false hasContentIssue false
  • English
  • Français

Nelfinavir in Expanded Postexposure Prophylaxis Causing Acute Hepatitis With Cholestatic Features TWo Case Reports

Published online by Cambridge University Press:  02 January 2015

Marcia Trapé  and
Sandra Barnosky
Marcia Trapé
Affiliation:
University of Connecticut, School of Medicine Farmington, Connecticut
Sandra Barnosky
Affiliation:
University of Connecticut, School of Medicine Farmington, Connecticut
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 6 , June 2001 , pp. 333 - 334
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

References

1.Centers for Disease Control and Prevention. CDC Public Health Service guidelines for the management of health care workers exposures to HIV and recommendations for post-exposure prophylaxis. MMWR 1998;47(RR-7):1–33.Google Scholar
2.Cardo, DM, Bell, DM. Bloodborne pathogen transmission in health care workers. Infect Dis Clin North Am 1997;11:331–346.CrossRefGoogle ScholarPubMed
3.Beach, JW. Chemotherapeutic agents for HIV infection: mechanism of action, pharmacokinetics, metabolism and adverse reactions. Clin Ther 1998;20:2–25.CrossRefGoogle ScholarPubMed
4.Pai, V, Nahata, M. Nelfinavir mesylate: a protease inhibitor. Ann Pharmacother 1999;33:325–339.CrossRefGoogle ScholarPubMed
5.Lewis, JH, Zimmerman, HJ. Drug and chemical-induced cholestasis. Clin Liver Dis 1999;3:433–464.CrossRefGoogle ScholarPubMed